Alopecia areata. Alopecia areata
Conditions
Interventions
Intervention 1: Topical Diphenylcyclopropenone weekly up to three months (once per week). Intervention 2: Topical Anthralin daily up to three months (once per day).
Treatment - Drugs
Topical Diphenylcyclopropenone weekly up to three months (once per week)
Topical Anthralin daily up to three months (once per day)
Sponsors
Tabriz University of Medical Sciences, assistance research
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1-Patients with a clinical diagnosis of alopecia areata during the last 3 months have not responded to treatment with corticosteroids. 2- Patients who have announced their complete satisfaction for the study. 3- patients older than 2 years. Exclusion criteria: 1- associated with other skin diseases. 2-severe dermatitis or severe urticaria by DCPC or anthralin. 3- In the past month have been treated another drugs. 4- patients with hematologic malignancies and blood dyscrasias. 5- pregnant women and lactating. 6- patients retarded and physically disabled.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of improvement. Timepoint: Every two weeks up to three months. Method of measurement: Physical Examination.;Duration of treatment. Timepoint: To three months after the intervention. Method of measurement: Physical Examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: Every two weeks up to three months. Method of measurement: Physical Examination.;Recurrence. Timepoint: Every month after completion of the intervention up to 3 months. Method of measurement: Physical Examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Hamideh Azimi
Tabriz University of Medical Sciences
Outcome results
None listed